Liver Cancer

Nivolumab Shows Promise as a Treatment Option for Advanced Liver Cancer

ASCO Annual Meeting
May 29, 2015

In an early-stage study, nivolumab (Opdivo) has shown encouraging results as a treatment for advanced liver cancer. Liver cancer is the leading cause of cancer deaths worldwide, accounting for more than 600,000 deaths each year. People diagnosed with advanced liver cancer especially need new treatment options, as there is currently only one drug approved by the U.S. Food and Drug Administration (FDA).

Cabozantinib Helps Manage Several Advanced Cancers and Shrink Bone Metastases

ASCO Annual Meeting
May 18, 2011

In a recent study, the drug cabozantinib helped manage various advanced cancers, particularly prostate, ovarian, and liver cancers. The drug also helped shrink bone metastases (cancer that has spread to the bone). Cabozantinib is a type of targeted therapy, which means it targets the cancer's specific genes, proteins, or the tissue environment that contributes to cancer growth and survival.

Subscribe to RSS - Liver Cancer